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Abstract  22 
Background: Accelerated gain in fat mass in the first months of life is considered to be a risk factor for 23 
adult diseases, given tracking of infancy fat mass into adulthood. Our objective was to assess the 24 
influence of early growth, type of feeding and maternal variables on fat mass in early life. 25 
Methods: In 300 healthy term infants we longitudinally measured fat mass percentage(FM%) by air-26 
displacement-plethysmography at 1, 3 and 6 months and abdominal visceral and subcutaneous fat, 27 
measured by ultrasound, at 3 and 6 months. 28 
Results: Both gain in FM% and weight-for-length in the first 3 months were positively associated with 29 
FM% at 6 months of age and visceral fat at 3 months of age. Gain in FM% and weight-for-length between 30 
3 and 6 months was positively associated with visceral fat at 6 months. Breastfeeding duration associated 31 
positively with subcutaneous fat, but not visceral fat at 3 and 6 months. Maternal characteristics did not 32 
associate with FM% or visceral fat at 3 or 6 months. 33 
Conclusion: Higher gain in FM% or in weight-for-length in the first postnatal months leads not only to 34 
higher FM%, but also more visceral fat. Exclusive breastfeeding appears to promote subcutaneous but 35 





The first three months of life are known to be a critical window for the programming of adiposity and 39 
cardiovascular diseases [1-3]. Unraveling the modifiable determinants that influence the adiposity and fat 40 
mass development in early life can provide valuable insights to support an optimal infant development. 41 
We have previously shown that the risk for type 2 diabetes and cardiovascular diseases at the age of 21 42 
years differs  according to weight-for-length gain during the first months of life, indicating that early growth 43 
might be a determinant for later life metabolic health [4]. One of the key elements driving early life growth 44 
is the nutrition provided to the young infant. Exclusive breastfeeding is the preferred feeding for newborn 45 
infants, being associated with a.o. less infections, better cognitive development, but also with a lower 46 
incidence of childhood obesity and type 1 and type 2 diabetes [5]. However, outcomes of studies on the 47 
influence of breastfeeding on infant’s body composition are not straight-forward [6-9].  48 
Apart from postnatal factors, a higher pre-pregnancy maternal weight and maternal weight gain during 49 
pregnancy has been associated with a higher infant weight and fat mass percentage at birth [10, 11]. 50 
Given the increasing prevalence of overweight in adult women, including those at reproductive ages [12], 51 
this could potentially contribute to a cross-generational vicious obesity circle. However, it is not known 52 
whether these maternal factors have a lasting influence on infant adiposity development. Most studies 53 
have focused on weight, length, and other anthropometric measures as a proxy for adiposity in infancy, 54 
instead of accurate body composition, but with air-displacement plethysmography infants body 55 
composition (i.e. fat and fat-free mass) can accurately be measured [13-15]. 56 
Total body fat has adverse consequences on adult disease risks, but location of body fat seems to be 57 
even more important. Abdominal visceral fat mass during childhood is associated with an unfavorable 58 
metabolic profile in later life [16, 17]. Recently, an ultrasound methodology has been validated to measure 59 
infant visceral fat and abdominal subcutaneous fat, enabling a non-invasive approach to obtain more 60 
insights in the development of these fat depots during infancy [18]. 61 
Our aim was to identify the determinants of total fat mass percentage (FM%), as well as visceral and 62 
abdominal subcutaneous fat in the first months of life. Our primary hypothesis was that, independent of 63 
birth weight, early weight gain between birth and 3 months and more specifically the gain in FM% 64 
between 1 and 3 months of age are associated with a higher fat mass and visceral fat mass at 3 and 6 65 
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months. Our secondary hypothesis was that longer duration of exclusive breastfeeding is associated with 66 
more subcutaneous fat. Our third hypothesis was that pre-pregnancy BMI  and maternal weight gain 67 
during pregnancy would negatively influence are associated with a higher infant FM% and visceral fat 68 
mass at 3 and 6 months.  69 
We, therefore, measured in a cohort of healthy term infants longitudinal total body composition by air-70 
displacement plethysmography at 1, 3 and 6 months of age as well as visceral and abdominal 71 
subcutaneous fat by ultrasound at 3 and 6 months of age and associated these outcomes with infant 72 




Material and Methods 75 
Subjects 76 
The study population consisted of 300 healthy term infants, who are embedded in a larger birth cohort 77 
study (Sophia Pluto Study) aimed at examining the postnatal determinants of body composition during 78 
infancy. Infants were recruited from several hospitals in and near Rotterdam, a large city in The 79 
Netherlands (600 000 habitants). All participants fulfilled the same inclusion criteria: 1) born at term (≥37 80 
weeks of gestation), 2) Age at recruitment <28 days, 3) uncomplicated neonatal period without severe 81 
asphyxia (defined as an Apgar score below three after five minutes), sepsis or long-term complication of 82 
respiratory ventilation. Exclusion criteria were known congenital or postnatal diseases that could interfere 83 
with body composition development, confirmed intra-uterine infection, maternal use of corticosteroids or a 84 
maternal medical condition that could interfere with infant’s body composition development (e.g. 85 
diabetes). The Medical Ethics Committee of Erasmus Medical Center approved the study. Written 86 
informed consent was obtained from both parents unless the mother was single.  87 
Data collection and measurements 88 
Parental and pregnancy characteristics 89 
Maternal data, i.e. pre-pregnancy weight and highest weight in pregnancy, height, parity, smoking, 90 
ethnicity and complications during pregnancy, were obtained from medical records and questionnaires. 91 
The Institute of Medicine published in 2009 revised gestational weight gain guidelines to minimize the 92 
negative health consequences for both mother and fetus of inadequate or excessive gain. They include 93 
four classifications of preconception body mass index (BMI; World Health Organization definitions); 94 
underweight, normal weight, overweight and obese. Maternal underweight was defined as a pre-95 
pregnancy BMI <18.5kg/m
2
, overweight as a BMI ≥25 kg/m
2




 Weight 96 
gain recommendations were given per pre-pregnancy BMI-category, include three categories; too less 97 
weight gain, normal weight gain and too much weight gain [19].  98 
Information regarding socioeconomic status, educational levels of the parents was obtained using 99 
questionnaires.  100 
The Dutch Standard Classification of Education was used to categorize mothers to one of four levels of 101 
education: high (university degree), mid-high (higher vocational training, Bachelor’s degree), mid-low (>3 102 
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years general secondary school, intermediate vocational training), low (no education, primary school, 103 
lower vocational training or 3 years or less general secondary school)[20].   104 
Infant characteristics 105 
Research clinic visits were scheduled at ages 1, 3 and 6 months. Birth data, such as gestational age, 106 
were taken from midwife- and hospital records. Information on breast- and formula feeding was asked at 107 
the clinic visits.  108 
Anthropometrics 109 
Weight was measured to the nearest gram by an electronic infant scale (Seca, Hanover, MD), length was 110 
measured twice in all infants by the same two persons using the two-persons technique to the nearest 0.1 111 
cm by a length measuring board (Seca). In case of >5mm deviation between the 2 measurements an 112 
additional measurement was performed and the mean of the measurements closest together were used.  113 
Standard deviation (SD) scores for birth length, birth weight, weight, length and weight for length were 114 
calculated to correct for gestational age and gender with Growth Analyser Research Calculation Tools 4.0 115 
(available at www.growthanalyser.org), according to Dutch age- and gender-matched reference values 116 
[21].  117 
Body composition 118 
Whole-body composition was estimated using air-displacement plethysmography (ADP) using the 119 
Peapod, Infant Body Composition System (COSMED) [14, 15, 22, 23]. Briefly, this ADP system assesses 120 
fat mass, fat mass percentage (FM%) and fat free mass and fat-free mass percentage by direct 121 
measurements of body volume and body mass, based on the whole-body densitometric principle. All 122 
measurements were obtained by experienced personnel, according to standardized protocol. The Peapod 123 
was calibrated every day, according to the protocol recommended by the supplier.  124 
Abdominal fat  125 
Visceral and abdominal subcutaneous fat were estimated at 3 and 6 months using a Prosound 2 126 
ultrasound (US), with a UST-9137 convex ultrasound transducer (both from Hitachi Aloka Medical, 127 
Switzerland). Two experienced researchers performed all US measurements, after an extra training to 128 
measure subcutaneous and visceral fat in infants. To assess the intra-observer and inter-observer 129 
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repeatability of the measurements, we calculated the intra-class and inter-class correlation coefficients 130 
(ICCs). The ICCs ranged from 0.75 to 0.97, indicating that our measurements were reproducible. For both 131 
measures, the transducer was positioned where the xiphoid line intercepted the waist circumference 132 
measurement plane. Visceral fat was estimated by measuring visceral depth, which is the distance in cm 133 
between the peritoneal boundary and the corpus of the lumbar vertebra, assessed in the longitudinal 134 
plane with the ultrasound probe depth set at 9 cm. Subcutaneous abdominal fat was estimated by the 135 
distance in cm between the cutaneous boundary and the linea alba at the same location, but on a 136 
transverse plane with a probe depth of 4 cm [18].  137 
Statistical analysis 138 
The number of infants at birth and at 1, 3 and 6 months is shown in Supplemental Figure 1. Baseline 139 
characteristics are expressed as means and standard deviation, as variables were normally distributed.  140 
Linear regression analyses were performed to determine associations between birth weight SDS, birth 141 
length SDS, change in body fat mass percentage (FM%)(delta FM%1-3mo) between 1 and 3 months of 142 
age, duration of exclusive breastfeeding, maternal pre-pregnancy BMI (as exact value and as 143 
category(according to [19]), maternal weight gain during pregnancy (as exact value and as category per 144 
pre-pregnancy BMI [19], and the outcome variables: FM%, visceral and abdominal subcutaneous fat at 145 
the age of 3 and 6 months, with adjustment for gender and age. 146 
Multiple linear regression (MR) analysis was performed to determine which variables contributed to the 147 
FM% and visceral and abdominal subcutaneous fat at the age of 6 months. All models were adjusted for 148 
birth weight SDS. First, we entered age, gender, duration of exclusive breastfeeding to the model ((Model 149 
A). Secondly, we added the change in FM% from age 1 to 3 months (delta FM%1-3mo) (Model B). Thirdly, 150 
we entered the change in weight for length SDS from age 0 to 1 months (delta W/LSDS0-1mo) instead of 151 
the delta FM%1-3mo (Model C). Finally, the change in weight for length SDS from age 1 to 3 months (delta 152 
W/LSDS1-3mo) was added instead of delta W/LSDS0-1mo (Model D).  153 
SPSS statistical package version 20.0 (SPSS Inc. Chicago, Illinois) was used for analysis. Results were 154 





Clinical characteristics 158 
Maternal and infant demographic characteristics are presented in Table 1, including the numbers of 159 
infants at every visit. The mean age of the mothers was 32.3 years and gestational age was 39.7 weeks. 160 
Fifty-eight percent of the infants were male and 87% were Caucasian.  161 
Mean fat mass percentage (FM%) increased from 16.7% at 1 month to 22.8% at 3 months and 23.8% at 162 
6 months of age, whereas mean visceral fat remained stable between 3 and 6 months of age. At start, 163 
240 infants received exclusive breastfeeding (80%), at 1 month 165 infants(55%), at 3 months 114 infants 164 
(38%) received exclusive breastfeeding and at 6 months 57 infants received exclusive breastfeeding. The 165 
mean(SD) duration of breastfeeding was 16(12) weeks.  166 
Mean(SD) maternal pre-pregnancy BMI was 24.5(4.7) kg/m
2
, maternal weight gain during pregnancy was 167 
14.0(10.4) kg. Of all mothers, 4% had an underweight pre-pregnancy BMI, 61% had a normal pre-168 
pregnancy BMI, 22% an overweight pre-pregnancy BMI and 13% an obese pre-pregnancy BMI. 169 
Weight gain during pregnancy differed between maternal pre-pregnancy BMI-category (p<0.001), with a 170 
substantially lower weight gain in obese mothers. 171 
Linear correlations with infant FM% at 6 months 172 
Table 2 shows the linear correlations of infant and maternal variables with FM% at 3 and 6 months, 173 
corrected for gender and age. 174 
Gain in FM% (delta FM%1-3mo) and in weight for length SDS (delta W/LSDS1-3mo)  between 1 and 3 175 
months of life were both positively associated with FM% at 6 months (all p<0.001). Duration of exclusive 176 
breastfeeding was positively associated with FM% at 6 months (p<0.01). None of the selected maternal 177 
variables including pre-pregnancy BMI and maternal weight gain during pregnancy were associated with 178 
FM% at 6 months. Similarly, there was no relation between the different pre-pregnancy BMI categories or 179 
weight gain categories per pre-pregnancy BMI and the FM% at 6 months. 180 
 Associations with visceral fat at 3 and 6 months 181 
Table 3 shows the linear associations, corrected for gender and age, of infant and maternal variables with 182 
visceral and subcutaneous fat at 3 and 6 months.  183 
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Visceral fat 184 
Delta FM%1-3mo was positively associated with visceral fat at 3 months (p=0.02) and delta FM%3-6mo with 185 
visceral fat at 6 months (p=0.02). Delta FM%1-3mo was not associated with visceral fat at 6 months 186 
(p=0.99). Similarly, delta W/LSDS1-3mo was positively associated with visceral fat at 3 months (p=0.01), 187 
but not at 6 months (p=0.95), while the delta W/LSDS3-6mo showed a positive trend with visceral fat at 6 188 
months (p=0.06).  189 
Subcutaneous fat 190 
Delta FM%1-3mo was positively associated with subcutaneous fat at 3 and 6 months (p=0.01, p<0.001, 191 
resp.) and delta FM%3-6mo  with subcutaneous fat at 6 months (p<0.001). Delta W/LSDS1-3mo was not 192 
associated with subcutaneous fat at 3 months (p=0.16), but both delta W/LSDS1-3mo and delta W/LSDS3-193 
6mo were associated with subcutaneous fat at 6 months (both p<0.001).  194 
Duration of exclusive breastfeeding was positively associated with subcutaneous fat at 3 and 6 months 195 
(p=0.01, p=0.01, resp.), but not with visceral fat (Table 3). 196 
Maternal pre-pregnancy BMI was neither associated with infant visceral nor with subcutaneous fat at 3 197 
and 6 months (neither as exact increase nor based on category). Also weight gain during pregnancy was 198 
not associated with visceral or subcutaneous fat at 3 and 6 months (neither as exact increase nor based 199 
on category). Parity was only positively associated with subcutaneous fat at 6 months (p=0.02). Other 200 
maternal variables were not associated with visceral or subcutaneous fat.  201 
Determinants of FM%, visceral and subcutaneous fat at 6 months of age 202 
To identify which of the variables were the most important determinants of FM% at 6 months, we 203 
performed multiple regression (MR) analyses (Table 4). Model A shows that female gender and duration 204 
of exclusive breastfeeding were positively associated with FM% at 6 months (β=2.719, p<0.001 and β= 205 
0.130, p<0.001, resp.). The change in FM% between the age of 1 and 3 months (delta FM%1-3mo) was 206 
positively associated with FM% at 6 months next to female gender and duration of exclusive 207 
breastfeeding (Model B). The change in W/L SDS between birth and 1 month (delta W/LSDS0-1mo) was 208 
not associated (Model C), but the change in W/L SDS between 1 and 3 months (delta W/LSDS1-3mo) was 209 
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positively associated with FM% at 6 months (β=2.249, p<0.001), next to female gender and duration of 210 
exclusive breastfeeding (Model D).  211 
As the gain in FM% (delta FM%3-6mo) and gain in weight for length delta W/LSDS3-6mo) between 3 and 6 212 
months (delta FM%3-6mo) were the only determinants of visceral fat at 6 months, we did not investigate 213 





In this longitudinal study with detailed body composition data during infancy, we found a strong 217 
association of gain in FM% and its proxy weight-for-length SDS in the first 3 months of life with FM% at 6 218 
months. Gain in FM% and in weight-for-length SDS between 1 and 3 months was associated with visceral 219 
fat at 3 months and a higher gain in FM% between 3 and 6 months was associated with more visceral fat 220 
at 6 months. Exclusive breastfeeding duration was positively associated with FM% and subcutaneous fat 221 
at 6 months, but not with visceral fat.  222 
The present study shows that especially the gain in FM% between 1 and 3 months leads to a higher FM% 223 
at 6 months and more visceral fat at 3 months. We have previously shown that infants with a higher FM% 224 
at 6 months, measured by DXA scan, tended to keep this higher FM% during childhood [24] and other 225 
studies showed that visceral fat in early life tends to track into childhood and adulthood [25-27]. Our 226 
results show that this might start as early as the first 3 months of life, emphasizing the need to monitor 227 
growth of infants closely from birth onwards. Long-term follow up of our study will hopefully reveal the 228 
potential long-term effects of the early growth trajectory on the amount and location of adiposity in this 229 
population.  230 
To our knowledge, this is the first study investigating the influence of pre-defined determinants of infant 231 
FM% as well as visceral and subcutaneous fat during the first 6 months of life. Infant growth velocity in 232 
the first 3 months of life, represented by gain in weight-for-length SDS was associated with higher FM% 233 
at 6 months. The impact of infancy weight for length SDS on body fat % might mediate its previously 234 
reported association with type 2 diabetes and cardiovascular diseases risk [28]. Moreover, these data 235 
support our previous findings, showing that young adults at the age of 21 years had higher risk for type 2 236 
diabetes and cardiovascular diseases when they had a higher gain in weight for length SDS in the first 3 237 
months, while after 3 months no associations between adiposity and risk factors at 21 years could be 238 
found. Our findings are in line with previous reports [2, 29]. 239 
We found no association between total body FM% and visceral fat, which is in line with the finding that in 240 
children total body FM% is more associated with subcutaneous fat rather than with visceral fat [30]. Our 241 
data show that associations with total FM% cannot be simply extrapolated to visceral fat and underline 242 
the need for detailed body composition assessment instead.  243 
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In contrast to our expectations, infants who were still exclusively breastfed at 6 months had a higher FM% 244 
at 6 months than those being exclusive formula fed. Exclusive breastfeeding during infancy has been 245 
associated with a lower risk of childhood obesity [31], but apparently this might not be caused by tracking 246 
of FM% from infancy. Interestingly, we found that the higher FM% associated with increased 247 
breastfeeding duration, could be primarily explained due to more subcutaneous fat and not to more 248 
visceral fat. One could postulate that if this difference in body fat distribution lasts throughout childhood, 249 
breastfed infants might have a more beneficial adiposity phenotype with a reduced risk for obesity and 250 
adult diseases [32].  251 
Apart from type of milk feeding, other parental and heritable factors might have more impact on the body 252 
composition and obesity risk of their infants. Surprisingly, maternal variables, like pre-pregnancy BMI, 253 
were not associated with infant FM% at 3 and 6 months. In a previous study, we showed that maternal 254 
BMI before pregnancy associates with FM% at birth [33] and also other studies have shown associations 255 
between maternal variables and FM% of newborns [10, 34], but apparently this is a transient effect which 256 
disappears after the first month of life. Our findings are in line with another study, showing that maternal 257 
BMI and weight gain during pregnancy had no influence on FM%, measured by DXA, in infants at 6 258 
months of age [35]. In addition, the current study demonstrates that the association between maternal 259 
variables and FM% of the infants as present at birth, disappeared already at the age of 3 months.  260 
In conclusion, our study shows that a higher gain in FM% in the first 3 months of life leads to more FM% 261 
at 6 months of age and more visceral fat at 3 months. Similar associations were found with a higher gain 262 
in weight for length during the first months of life. These might underlie the reported long-term 263 
associations between rapid changes in weight for length SDS in early life and risks for obesity and adult 264 
diseases in later life. We also show that the consistently reported association between exclusive 265 
breastfeeding and higher total body FM% in mid-infancy appears to be due to higher subcutaneous fat, 266 
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Table 1. Maternal and infant characteristics 373 
 Mean SD 
Infant characteristics   
 Gender (boys) (%) 58  
 Mode of delivery (cesarean delivery) (%) 32.3  
 Gestational age (weeks) 39.7 1.2 
 Birth weight SDS -0.38 1.1 
 Birth length SDS -0.23 1.2 
 At 1 month (n=300)   
 Weight SDS  -0.30 1.2 
 Length SDS  0.03 0.9 
 Fat mass%  16.7 4.6 
 At 3 months (n=268)   
 Weight SDS 0.47 1.1 
 Length SDS  0.36 0.9 
 Fat mass%  22.8 5.1 
 US-visceral fat (cm) 2.54 0.6 
 US-abdominal subcutaneous fat (cm) 0.42 0.1 
 At 6 months (n=248)   
 Weight SDS  0.20 1.0 
 Length SDS  0.23 0.8 
 Fat mass%  23.8 5.3 
 US-visceral fat (cm) 2.47 0.6 
 US-abdominal subcutaneous fat (cm) 0.44 0.1 
 Duration of breastfeeding (wks) 16 12 
 Exclusive breastfeeding at 1 month (%) 55  
 Exclusive breastfeeding at 3 month (%) 38  
 Exclusive breastfeeding at 3 month (%) 19  
Maternal characteristics   
 Age (y) 32.3 4.8 
 Height (cm) 168 6.7 
 Pre-pregnancy weight (kg) 69.7 13.6 
 Pre-pregnancy BMI (kg/m
2
)  24.5 4.7 
 Weight gain during pregnancy (kg)  14.0 10.4 
 Highest weight in pregnancy (kg) 83.8 16.1 
 Highest BMI in pregnancy (kg/m
2
) 29.4 5.6 
 Weight gain per pre-pregnancy BMI-category*   
  Underweight pre-pregnancy BMI(<18.5) (4%) 15.7 4.9 
  Normal pre-pregnancy BMI (18.5-24.9) (61%) 14.1 8.5 
  Overweight pre-pregnancy BMI (25.0-30.0) (22%) 17.4 7.8 
  Obese pre-pregnancy BMI (>30.0) (13%) 7.3 18.5 
 Smoking during pregnancy (%) 4.7  
 Caucasian ethnicity (%) 87  
 Educational level (%)   
  High  26  
  Mid-high  25  
  Mid-low  21  
18 
 
  Low  4  
  Other or unknown 23  
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Table 2. Associations of FM% at 3 and 6 months with infant and maternal variables  377 
Values presented are results of multiple linear regression. β=unstandardized regression coefficient. All models are adjusted for 378 
gender and age. ^=Adjusted for birth weight. W/LSDS = weight for length SDS. Delta W/LSDS= gain in weight for length SDS. Delta 379 
FM%=gain in FM%. Significant p-values are indicated in boldface 380 
 381 
 FM% at 3 months FM% at 6 months 
 β p-value β p-value 
Infant characteristics     
 Gestational age (weeks) -0.67 0.01 -0.40 0.18 
 Birthweight SDS 0.11 0.71 -0.14 0.68 
 Birth length SDS -0.10 0.78 -0.01 0.99 
 At 1 month     
 W/L SDS 1.58 <0.001 0.96 0.02 
 FM%  0.46 <0.001 0.32 <0.001 
 Delta W/L SDS0-1mo 1.05 0.08 0.59 0.34 
 At 3 months     
 W/L SDS 2.94 <0.001 2.10 <0.001 
 FM%   0.72 <0.001 
 Delta W/L SDS1-3mo 2.86 <0.001 2.53 <0.001 
 Delta FM%1-3mo 0.53 <0.001 0.40 <0.001 
 At 6 months     
 W/LSDS   2.87 <0.001 
 Delta W/L SDS3-6mo   1.92 0.002 
 Delta FM%3-6mo   0.52 <0.001 
 Duration of exclusive breastfeeding (wks) 0.08 0.02 0.13 <0.01 
Maternal variables^     
 Age (y) 0.07 0.33 0.13 0.10 
 Height of mother (cm) -0.06 0.38 -0.03 0.61 
 Maternal pre-pregnancy BMI (kg/m
2
)  -0.15 0.11 -0.10 0.31 
 Maternal weight gain during pregnancy (kg) 0.01 0.76 0.01 0.83 
 Parity mother  0.88 0.04 0.55 0.23 
 Smoking mother during pregnancy (yes/no) 0.87 0.58 1.16 0.49 
 Ethnicity 0.17 0.06 0.18 0.09 
 Educational level 0.00 0.36 0.00 0.83 
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Table 3. Associations of ultrasound measurements at 3 and 6 months with infant and maternal variables. 
Values presented are results of multiple linear regression. β=unstandardized regression coefficient. All models are adjusted for gender and age. W/LSDS = weight for length SDS. Delta 
W/LSDS= gain in weight for length SDS. Delta FM%=gain in FM% 
Significant p-values are indicated in boldface. 
 At 3 months  At 6 months 
 Visceral fat Subcutaneous fat  Visceral fat Subcutaneous fat 
 β p-value β p-value  β p-value β p-value 
Infant variables          
 Gestational age (weeks) -0.05 0.13 0.01 0.07  0.00 0.74 0.00 0.68 
 Birthweight SDS -0.02 0.67 0.00 0.35  0.04 0.83 0.00 0.84 
 Birth length SDS -0.03 0.45 0.01 0.15  0.10 0.01 0.00 0.88 
 At 1 month          
 W/L SDS 0.02 0.76 0.02 0.04  0.03 0.52 0.02 0.05 
 FM%  -0.01 0.11 0.01 0.01  0.00 0.62 0.00 0.30 
 Delta W/L SDS0-1mo -0.13 0.07 0.05 0.002  0.07 0.31 0.00 0.88 
 At 3 months          
 W/LSDS 0.07 0.20 0.04 <0.001  0.04 0.44 0.04 <0.001 
 FM% 0.00 0.63 0.01 <0.01  0.00 0.76 0.01 <0.001 
 Delta W/L SDS1-3mo 0.16 0.01 0.02 0.16  0.00 0.95 0.04 <0.001 
 Delta FM%1-3mo 0.02 0.02 0.01 0.01  0.00 0.99 0.01 <0.001 
 At 6 months          
 W/L SDS      0.10 0.02 0.05 <0.001 
 FM%      0.09 0.09 0.01 <0.001 
 Delta W/L SDS3-6mo      0.14 0.06 0.04 0.004 
 Delta FM%3-6mo      0.03 0.02 0.01 <0.001 
 Duration of exclusive breastfeeding (wks) 0.00 0.49 0.00 0.01  0.00 0.74 0.00 0.01 
Maternal variables          
 Age(y) 0.00 0.91 0.00 0.57  0.02 0.13 0.00 0.06 
 Height of mother (cm) -0.01 0.08 0.00 0.64  -0.01 0.19 0.00 0.05 
 Maternal pre-pregnancy BMI (kg/m2) 0.01 0.43 0.00 0.13  0.00 0.18 0.00 0.57 
 Maternal weight gain during pregnancy (kg) 0.01 0.14 0.00 0.46  0.00 0.18 0.00 0.20 
 Parity mother -0.02 0.79 0.02 0.15  0.07 0.17 0.02 0.02 
 Smoking mother during pregnancy (yes/no) 0.30 0.11 -0.07 0.10  0.00 1.00 -0.01 0.78 
 Ethnicity 0.00 0.78 0.00 0.65  0.02 0.09 0.00 0.17 
 Educational level 0.00 0.47 0.00 0.42  0.00 0.62 0.00 0.42 
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*gender:0=boys, 1=girls W/LSDS = weight for length SDS. Delta W/LSDS= gain in weight for length SDS. Delta FM%=gain in FM%. Significant p-values are indicated in boldface. All 
models were adjusted for birth weight SDS 
 Model A Model B Model C Model D 
 β p β p β p β p 
Age (months) 1.351 0.499 2.354 0.214 1.973 0.328 1.481 0.444 
Gender* 2.719 0.001 3.025 <0.001 2.673 0.001 3.259 <0.001 
Duration of breastfeeding (wks) 0.130 <0.001 0.111 0.001 0.148 <0.001 0.128 <0.001 
Delta FM%1-3mo   0.459 <0.001     
Delta W/LSDS0-1mo     -0.322 0.521   
Delta W/LSDS1-3mo       2.249 <0.001 
Overall p-value <0.001 <0.001 <0.001 <0.001 
Adjusted R
2 
0.166 0.297 0.139 0.243 
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Supplemental figure 1. Participants flow diagram 
 
